Th22 cells increase in poor prognosis multiple myeloma and promote tumor cell growth and survival

There is increased production of plasmacytoid dendritic cells (pDCs) in the bone marrow (BM) of multiple myeloma (MM) patients and these favor Th22 cell differentiation. Here, we found that the frequency of interleukin (IL)-22(+)IL-17(−)IL-13(+) T cells is significantly increased in peripheral blood...

Full description

Saved in:
Bibliographic Details
Published in:Oncoimmunology
Main Authors: Di Lullo, Giulia, Marcatti, Magda, Heltai, Silvia, Brunetto, Emanuela, Tresoldi, Cristina, Bondanza, Attilio, Bonini, Chiara, Ponzoni, Maurilio, Tonon, Giovanni, Ciceri, Fabio, Bordignon, Claudio, Protti, Maria Pia
Format: Artigo
Language:Inglês
Published: Taylor & Francis 2015
Subjects:
Original Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4485827/
https://ncbi.nlm.nih.gov/pubmed/26155400
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2015.1005460
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items